These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10965168)

  • 41. Adult disseminated primary papular xanthoma treated with doxycycline.
    Bastida J; Camacho-Galán R; Armesto-Fernández MA; Díaz-Cascajo C
    Arch Dermatol; 2007 May; 143(5):667-9. PubMed ID: 17519219
    [No Abstract]   [Full Text] [Related]  

  • 42. Xanthoma disseminatum with large plaques confined to the back, pulmonary involvement and multiple intestinal xanthomas.
    Hisanaga Y; Akaike Y; Kuroda K
    Dermatology; 2004; 208(2):164-6. PubMed ID: 15057010
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Xanthoma disseminatum: a case report and literature review.
    Alexander AS; Turner R; Uniate L; Pearcy RG
    Br J Radiol; 2005 Feb; 78(926):153-7. PubMed ID: 15681329
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumefactive demyelinating lesions in a patient with multiple sclerosis receiving natalizumab.
    Moghadasi AN; Baghbanian SM
    Acta Neurol Belg; 2019 Mar; 119(1):137-139. PubMed ID: 29876751
    [No Abstract]   [Full Text] [Related]  

  • 45. Xanthoma disseminatum with progressive involvement of the central nervous and hepatobiliary systems.
    Knobler RM; Neumann RA; Gebhart W; Radaskiewicz T; Ferenci P; Widhalm K
    J Am Acad Dermatol; 1990 Aug; 23(2 Pt 2):341-6. PubMed ID: 2394852
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The nature of the demyelinating process in clinical and experimental neurology].
    Markov DA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(7):967-75. PubMed ID: 5368925
    [No Abstract]   [Full Text] [Related]  

  • 47. Non-multiple sclerosis recurrent demyelinating disorders: an ongoing debate.
    Marchioni E; Tavazzi E; Bastianello S
    Brain; 2010 Aug; 133(Pt 8):e150; author reply e151. PubMed ID: 20435629
    [No Abstract]   [Full Text] [Related]  

  • 48. Xanthoma disseminatum: case report.
    Celić D; Rados J; Lipozencić J; Dobrić I
    Acta Dermatovenerol Croat; 2004; 12(4):282-8. PubMed ID: 15588563
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Etiologic correlations between idiopathic polyneuritis and multiple sclerosis: therapeutic implications.
    Arnason BG; Mantos JJ
    Mod Treat; 1970 Sep; 7(5):903-17. PubMed ID: 4326376
    [No Abstract]   [Full Text] [Related]  

  • 50. Lethal acute demyelinization with encephalo-myelitis as a complication of cured Cushing's disease.
    Chevalier N; Hieronimus S; Vandenbos F; Delmont E; Cua E; Cherick F; Paquis P; Michiels JF; Fenichel P; Brucker-Davis F
    Ann Endocrinol (Paris); 2010 Dec; 71(6):548-52. PubMed ID: 20850107
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative analysis of coronavirus JHM-induced demyelinating encephalomyelitis in Lewis and Brown Norway rats.
    Watanabe R; Wege H; ter Meulen V
    Lab Invest; 1987 Oct; 57(4):375-84. PubMed ID: 2444766
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The pathology of multiple sclerosis.
    Lucchinetti CF; Parisi J; Bruck W
    Neurol Clin; 2005 Feb; 23(1):77-105, vi. PubMed ID: 15661089
    [No Abstract]   [Full Text] [Related]  

  • 53. [Neuromyelitis optica or acute form of disseminated encephalomyelitis?].
    David E; Schulze HA
    Psychiatr Neurol Med Psychol (Leipz); 1969 Jan; 21(1):15-20. PubMed ID: 5799816
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical aspects, course and therapy of disseminated encephalomyelitis in chronic acquired toxoplasmosis].
    Zinchenko AP; Merkulova GP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(2):178-83. PubMed ID: 4466244
    [No Abstract]   [Full Text] [Related]  

  • 55. Poly ICLC in the treatment of postinfectious demyelinating encephalomyelitis.
    Salazar AM; Engel WK; Levy HB
    Arch Neurol; 1981 Jun; 38(6):382-3. PubMed ID: 7236070
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Infiltrative chiasmatopathy in xanthoma disseminatum: a rare entity.
    Banerjee M; Sharma P; Gaur N; Takkar B
    BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567219
    [No Abstract]   [Full Text] [Related]  

  • 57. [Demyelinating diseases].
    Reznik M
    Rev Med Liege; 1972 Jan; 27(2):29-38. PubMed ID: 4552243
    [No Abstract]   [Full Text] [Related]  

  • 58. [Vinblastine treatment for extensive non-X histiocytosis (xanthoma disseminatum)].
    Pruvost C; Picard-Dahan C; Bonnefond B; Grossin M; Gehanno P; Souteyrand P; Crickx B; Belaich S
    Ann Dermatol Venereol; 2004 Mar; 131(3):271-3. PubMed ID: 15107746
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Viral infections and demyelinating diseases.
    Weiner LP; Johnson RT; Herndon RM
    N Engl J Med; 1973 May; 288(21):1103-10. PubMed ID: 4348989
    [No Abstract]   [Full Text] [Related]  

  • 60. Disfiguring Nodular Cephalic Xanthoma Disseminatum: An Exceptional Variant of a Forgotten Entity.
    Bonometti A; Gliozzo J; Moltrasio C; Bagnoli F; Venegoni L; Passoni E; Paulli M; Berti E
    Acta Derm Venereol; 2019 Apr; 99(4):450-451. PubMed ID: 30628633
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.